Suppr超能文献

妈富隆的临床疗效

[Clinical effectiveness of Marvelon].

作者信息

Marianowski L, Grzechocińska B

机构信息

I Katedry i Kliniki Połoznictwa i Ginekologii AM w Warszawie.

出版信息

Ginekol Pol. 1995 May;66(5):294-6.

PMID:8522228
Abstract

Clinical results of a new contraceptive pills--Marvelon (Organon) were studied. 32 women, ages 30 +/- 5 years, participated in the study during at least 6 cycles. Marvelon was good tolerated and subjective side-effects were very low. The cycles were regular, duration of withdrawal bleeding was 3-5 days and the amount of the blood lost were unchanged or milder. Marvelon didn't affect body weight and blood pressure. Favourable lipid profile--increased a mean level of HDL-Cholesterol and decreased a mean level of LDL-Cholesterol were noticed. Pearl Index was 0,0.

摘要

对一种新型避孕药——妈富隆(欧加农公司生产)的临床效果进行了研究。32名年龄在30±5岁的女性参与了至少6个周期的研究。妈富隆耐受性良好,主观副作用非常低。月经周期规律,撤退性出血持续时间为3 - 5天,失血量未变或减少。妈富隆不影响体重和血压。观察到有利的血脂状况——高密度脂蛋白胆固醇平均水平升高,低密度脂蛋白胆固醇平均水平降低。Pearl指数为0.0。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验